Related Experiment Video
Updated: Aug 10, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Electric Cardioversion vs. Pharmacological with or without Electric Cardioversion for Stable New-Onset Atrial
Paritosh Prasai1, Dhan Bahadur Shrestha2, Eltaib Saad1
1Department of Internal Medicine, Ascension Health St. Francis Hospital, Evanston, IL 60202, USA.
Insights
Pharmacological cardioversion and electrical cardioversion show similar success rates for new-onset atrial fibrillation. This meta-analysis found no significant differences in outcomes for stable patients, with electrical cardioversion having lower hypotension rates.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Research
Background:
- Lack of consensus exists regarding the preferred cardioversion method for hemodynamically stable new-onset atrial fibrillation (NOAF) patients in the emergency department (ED).
- Pharmacological cardioversion (PC) and electrical cardioversion (EC) are both utilized, necessitating a comparative analysis.
Purpose of the Study:
- To compare the efficacy and safety of pharmacological cardioversion (PC) versus electrical cardioversion (EC) for hemodynamically stable new-onset atrial fibrillation (NOAF) patients.
- To evaluate successful restoration of sinus rhythm and secondary outcomes including revisits, readmissions, length of stay, and adverse events.
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies published up to March 7, 2022.
- Searched PubMed, PubMed Central, Embase, Scopus, and Cochrane databases.
- Primary outcome: successful sinus rhythm restoration; Secondary outcomes: ED revisits, hospital readmissions, length of stay, adverse events.
Main Results:
- No significant difference in successful sinus rhythm restoration rates between PC and EC (88.66% vs. 85.25%).
- No statistical differences observed in ED revisits, hospital readmissions, or length of stay.
- Electrical cardioversion (EC) was associated with a lower incidence of hypotension compared to pharmacological cardioversion (PC).
Conclusions:
- Pharmacological cardioversion (PC) and electrical cardioversion (EC) demonstrate comparable success rates for restoring sinus rhythm in hemodynamically stable new-onset atrial fibrillation (NOAF) patients.
- Neither method showed superiority regarding revisits, readmissions, or length of hospital stay.
- Electrical cardioversion (EC) may be preferred due to a lower risk of hypotension.
Background:
There is no clear consensus on the preference for pharmacological cardioversion (PC) in comparison to electric cardioversion (EC) for hemodynamically stable new-onset atrial fibrillation (NOAF) patients presenting to the emergency department (ED).
Methods:
A systematic review and meta-analysis was conducted to assess PC (whether being followed by EC or not) vs. EC in achieving cardioversion for hemodynamically stable NOAF patients. PubMed, PubMed Central, Embase, Scopus, and Cochrane databases were searched to include relevant studies until 7 March 2022. The primary outcome was the successful restoration of sinus rhythm, and secondary outcomes included emergency department (ED) revisits with atrial fibrillation (AF), hospital readmission rate, length of hospital stay, and cardioversion-associated adverse events.
Results:
A total of three randomized controlled trials (RCTs) and one observational study were included. There was no difference in the rates of successful restoration to sinus rhythm (88.66% vs. 85.25%; OR 1.14, 95% CI 0.35-3.71; n = 868). There was no statistical difference across the two groups for ED revisits with AF, readmission rates, length of hospital stay, and cardioversion-associated adverse effects, with the exception of hypotension, whose incidence was lower in the EC group (OR 0.11, 95% CI 0.04-0.27: n = 727).
Conclusion:
This meta-analysis suggests that there is no difference in successful restoration of sinus rhythm with either modality among patients with hemodynamically stable NOAF.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management
Electroconvulsive Therapy
Cardiopulmonary Resuscitation III: AED Use
Dysrhythmias V: Evaluating Dysrhythmias

